Chemical Probe-Based Nanopore Sequencing to Selectively Assess the RNA Modifications.
Soundhar RamasamyVinodh J SahayasheelaSurbhi SharmaZutao YuTakuya HidakaLi CaiVaijayanthi ThangavelHiroshi SugiyamaGanesh N PandianPublished in: ACS chemical biology (2022)
Nanopore direct RNA sequencing (dRNA-Seq) reads reveal RNA modifications through consistent error profiles specific to a modified nucleobase. However, a null data set is required to identify actual RNA modification-associated errors for distinguishing it from confounding highly intrinsic sequencing errors. Here, we reveal that inosine creates a signature mismatch error in dRNA-Seq reads and obviates the need for a null data set by harnessing the selective reactivity of acrylonitrile for validating the presence of actual inosine modifications. Selective reactivity of acrylonitrile toward inosine altered multiple dRNA-Seq parameters like signal intensity and trace value. We also deduced the stoichiometry of inosine modification through deviation in signal intensity and trace value using this chemical biology approach. Furthermore, we devised Nano ICE-Seq, a protocol to overcome the low coverage issue associated with direct RNA sequencing. Taken together, our chemical probe-based approach may facilitate the knockout-free detection of disease-associated RNA modifications in clinical scenarios.
Keyphrases
- single cell
- rna seq
- genome wide
- big data
- single molecule
- electronic health record
- living cells
- high intensity
- patient safety
- nucleic acid
- climate change
- heavy metals
- randomized controlled trial
- healthcare
- gene expression
- adverse drug
- risk assessment
- label free
- loop mediated isothermal amplification
- fluorescent probe
- affordable care act
- wild type